<DOC>
	<DOCNO>NCT00816517</DOCNO>
	<brief_summary>Psoriasis vulgaris chronic disease psoriatic plaque may appear knee , elbow , scalp trunk . Evidence suggest role neurogenic inflammation pathogenesis psoriasis . Botulinum toxin show effect inhibit neurogenic inflammation . Recently , report patient suffer dystonia concomitant psoriasis , treat botulinum toxin dystonia note dramatic improvement psoriatic lesion . This pilot study determine safety efficacy botulinum toxin management psoriasis vulgaris .</brief_summary>
	<brief_title>Use Botulinum Toxin Treat Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Healthy subject . Psoriasis vulgaris diagnosis make board certified dermatologist involve least one area intolerant recalcitrant least two form recognize topical systemic treatment past . In addition , subject least score 2 keratoderma erythema . Signed informed consent . Willing adhere protocol . Immunosuppressed patient , pregnant , secondary skin infection , phototherapy within 4 week botulinum toxin injection , exposure topical systemic retinoid treatment last 12 month , volunteer take chloroquine hydroxychloroquine , volunteer warfarin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Botulinum toxin</keyword>
</DOC>